Patients Are Taking Insurance Denials Straight to the C-Suite

Frustrated patients are skipping the traditional appeals process and taking coverage denials directly to insurance company executives, Becker's Hospital Review reported, citing an Oct. 8 MedPage Today story. In two recent cases, patients secured approvals after contacting insurer leadership. In one, an insurer reversed course and approved chemotherapy once the patient reached an executive.

The pattern reflects a broader breakdown in how denials and appeals work. Standard processes are slow, confusing, and often require multiple rounds of paperwork and clinical documentation. Patients facing time-sensitive care, like cancer treatment, cannot always wait. Reaching a named decision-maker can cut through the bureaucracy in ways the official channel does not.

But going to the C-suite is not a reliable solution. It depends on a patient's persistence, savvy, and ability to find the right contact, advantages many sick patients lack. The trend signals mounting public pressure on insurers over denial practices, and it underscores why providers and regulators continue pushing for faster, more transparent prior authorization and appeals.